Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹56.8 LAdmitted-Finance | L1 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Eisai Pharmaceuticals India Pvt Ltd L1 |
|---|---|---|---|---|
| 1.00 | PVMS No 010569, Peg-Interferon beta 1a (r-DNA origin) 125 mcg/0.5ml Prefilled Pen | 336 | PFP | 50,71,920 ₹56,80,550.4 Lowest |
Tender Value
Refer Docs
Closing Date
19 Aug 2025, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DDG (Prov), O/o DGAFMS
DDG(Prov) O/o DGAFMS Ministry of Defence 5th Floor, A Block, Defence Offices Complex Africa Avenue New Delhi 110023
Supply of PVMS No 010569, Peg-Interferon beta 1a (r-DNA origin) 125 mcg/0.5ml Prefilled Pen
2025_ARMY_721199_1
RC/25-26/56
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
New Delhi
AS per RFP
6 documents required · 6 mandatory
₹0
Exempted
2 Dec 2025
18 Jul 2025
19 Aug 2025
18 Jul 2025
19 Aug 2025
1 Aug 2025
18 Jul 2025 - 1 Aug 2025
stage.html
html • 0.03 MB
technical_807323.pdf
techsummary_807323.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.46 MB
RFP.pdf
Tender Documents • 0.68 MB
BOQ_807323.xls
BOQ • 0.26 MB
AdditionalInfoOnGST.xls
Additional Documents • 0.03 MB
AdditionalDocument.pdf
Additional Documents • 0.16 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .